Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Vinbiocare Biotechnology
Arcturus Leaps On COVID-19 Trials And Investor Interest In mRNA
Singapore has granted approval for a Phase I/II trial of Arcturus’s next generation mRNA COVID-19 vaccine candidates, hot on the heels of a similar approval from Vietnam earlier this week. The biotech’s share price duly rocketed, but there may be more at play.
- Contract Manufacturing Organization
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.